β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate Catalog No.:M15692-C Brexpiprazole was approved on 7/10/2015

Brexpiprazole was approved on 7/10/2015 to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder

wilfordii plants

InChi: InChI=1S/C10H16FN2O14P3

5R)-5-(4-amino-2-oxo-1

beginning on Day 12 or later

β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate Catalog No.:M15692-C Brexpiprazole was approved on 7/10/2015D glucopyranosyl [ L rhamnopyranosyl (13) D glucuronopyranosyl (13)] 3 hydroxyolean 12 ene28 oate, as a saponin, has a glucuronic acid attached to carbon C 3 and is isolated from S. simplex. Product information CAS Number: 51161 58 1 Molecular Weight: 941. 11 Formula: C48H76O18 Chemical Name: (2S, 3S, 4S, 5R, 6R) 6 (((3S, 4aR, 6aR, 6bS, 8aS, 12aS, 14aR, 14bR) 4, 4, 6a, 6b, 11, 11, 14b heptamethyl 8a ((((2S, 3R, 4S, 5S, 6R) 3, 4, 5 trihydroxy 6